🐜
|
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study.
14 auth.
M. Kaya,
M. Ozkan,
O. Gunebakmaz,
H. Akkaya,
E. Kaya,
M. Akpek,
N. Kalay,
M. Dikilitas,
M. Yarlıoglues,
H. Karaca,
...
V. Berk,
İdris Ardiç,
A. Ergin,
Y. Lam
|
8 |
2013 |
8 🐜
|
🦁
|
Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
8 auth.
M. Akpek,
M. Kaya,
Y. Lam,
O. Sahin,
D. Elçik,
T. Celik,
...
A. Ergin,
C. Gibson
|
7 |
2012 |
7 🦁
|
🦁
|
Protective effects of spironolactone against anthracycline‐induced cardiomyopathy
11 auth.
M. Akpek,
I. Ozdoğru,
O. Sahin,
M. Inanc,
A. Dogan,
C. Yazıcı,
...
V. Berk,
H. Karaca,
N. Kalay,
A. Oğuzhan,
A. Ergin
|
7 |
2015 |
7 🦁
|
🐜
|
Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis
10 auth.
N. Kalay,
O. Doğdu,
F. Koç,
M. Yarlıoglues,
İdris Ardiç,
M. Akpek,
...
Davran Çiçek,
A. Oğuzhan,
A. Ergin,
M. Kaya
|
7 |
2012 |
7 🐜
|
🐜
|
Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
11 auth.
M. Kaya,
M. Akpek,
Y. Lam,
M. Yarlıoglues,
T. Celik,
O. Gunebakmaz,
...
M. Duran,
Ş. Ulucan,
A. Keser,
A. Oğuzhan,
M. Gibson
|
7 |
2013 |
7 🐜
|
🐜
|
Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
14 auth.
M. Kaya,
H. Uyarel,
M. Akpek,
N. Kalay,
M. Ergelen,
E. Ayhan,
T. Işik,
G. Çiçek,
D. Elçik,
Ömer Sahin,
...
Said Cosgun,
A. Oğuzhan,
M. Eren,
C. Gibson
|
6 |
2012 |
6 🐜
|
🐜
|
Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
9 auth.
O. Turak,
F. Ozcan,
A. Işleyen,
D. Tok,
E. Sokmen,
E. Buyukkaya,
...
S. Aydoǧdu,
M. Akpek,
M. Kaya
|
6 |
2012 |
6 🐜
|
🦁
|
Does COVID-19 Cause Hypertension?
M. Akpek
|
6 |
2021 |
6 🦁
|
🦁
|
The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI.
13 auth.
M. Akpek,
M. Kaya,
H. Uyarel,
M. Yarlıoglues,
N. Kalay,
O. Gunebakmaz,
O. Doğdu,
İdris Ardiç,
D. Elçik,
O. Sahin,
...
A. Oğuzhan,
A. Ergin,
C. Gibson
|
6 |
2011 |
6 🦁
|
🐜
|
Relation Between Mean Platelet Volume and Severity of Atherosclerosis in Patients With Acute Coronary Syndromes
14 auth.
S. Murat,
M. Duran,
N. Kalay,
O. Gunebakmaz,
M. Akpek,
C. Doger,
D. Elçik,
A. Ocak,
M. Vatankulu,
M. Turfan,
...
H. Kasapkara,
F. Akın,
M. Sahin,
M. Kaya
|
6 |
2013 |
6 🐜
|